Identification of a functionally impaired allele of human novel oxidoreductase 1 (NDOR1), NDOR1*1

Pharmacogenetics and Genomics

Volumn 15, Issue 6, 2005, Pages 381-386

  Finn, Robert D ^a   Wilkie, Murray ^a   Smith, Gillian ^a   Paine, Mark J I ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Drug metabolism; NADPH binding; NDOR1; Polymorphism

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; CYTOCHROME B5 REDUCTASE; CYTOCHROME P450 REDUCTASE; DIFLAVIN REDUCTASE; FLAVINE ADENINE NUCLEOTIDE; GENOMIC DNA; ISOLEUCINE; NITRIC OXIDE SYNTHASE; NOVEL OXIDOREDUCTASE 1; OXIDOREDUCTASE; POTASSIUM FERRICYANIDE; POTASSIUM FERRICYANIDE REDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG; VALINE;

ALLELE; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CANCER; CAUCASIAN; CODON; DNA SEQUENCE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME ASSAY; ESCHERICHIA COLI; EXON; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; INTRON; JAPAN; NDOR1 GENE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION;

ESCHERICHIA COLI;

EID: 20644436476     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01213011-200506000-00002     Document Type: Article

References (17)

1. Paine MJI, Garner AP, Powell D, Sibbald J, Sales M, Pratt N, et al. Cloning and characterisation of a novel human dual flavin reductase. J Biol Chem 2000; 275:1471-1478.
2. Dignam JD, Strobel HW. Preparation of homogeneous NADPH-cytochrome P450 reductase from rat liver. Biochem Biophys Res Commun 1975; 63:845-852.
3. Yasukochi Y, Masters B. Some properties of a detergent-solubilised NADPH-cytochrome c (cytochrome P450) reductase purified by biospecific affinity chromatography. J Biol Chem 1976; 251:5337-5344.
4. Bredt DS, Hwang PM, Glatt C, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P450 reductase. Nature. 1991; 351:714-718.
5. 2+/ calmodulin-independent diaphorase and reductase activities. Biochemistry 1992; 31:3243-3249.
6. Leclerc D, Wilson A, Dumas R, Gafuik C, Song D, Watkins D, et al. Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci USA 1998; 95:3059-3064.
7. Olteanu H, Banerjee R. Redundancy in the pathway for redox regulation of mammalian methionine synthase: reductive activation by the dual flavoprotein novel reductase 1. J Biol Chem 2003; 278:38310-38314.
8. Kwasnicka DA, Krakowiak A, Thacker C, Brenner C, Vincent SR. Coordinate expression of NADPH-dependent flavin reductase, Fre-1, and Hint-related 7meGMP-directed hydrolase, DCS-1. J Biol Chem 2003; 278: 39051-39058.
9. Finn RD, Basran J, Roitel O, Wolf CR, Munro AW, Paine MJI, et al. Determination of the redox potentials and electron transfer properties of the FAD- and FMN-binding domains of the human oxidoreductase NR1. Eur J Biochem 2003; 270:1164-1175.
10. Vasquez-Vivar J, Martasek P, Hogg N, Masters BS, Pritchard KA Jr, Kalyanaraman B. Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin. Biochemistry 1997; 36:11293-11297.
11. Garner AP, Paine MJ, Rodriguez-Crespo I, Chinje EC, Orti Z, De Montellano P, et al. Nitric oxide syntheses catalyze the activation of redox cycling and bioreductive anticancer agents. Cancer Res 1999; 59:1929-1934.
12. Fluck CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, et al. Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet 2004; 36:228-230.
13. Wilson A, Leclerc D, Rosenblatt DS, Gravel RA. Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. Hum Molec Genet 1999; 8:2009-2016.
14. Wilson A, Platt R, Wu Q, Leclerc D, Christensen B, Yang H, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Molec Genet Metab 1999; 67:317-323.
15. Olteanu H, Munson T, Banerjee R. Differences in the efficiency of reductive activation of methionine synthase and exogenous electron acceptors between the common polymorphic variants of human methionine synthase reductase. Biochemistry 2002; 41:13378-13385.
16. Yashimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, et al. A missense glu298asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998; 103:65-69.
17. Kobashi G, Yamada H, Ohta K, Kato E-H, Ebina Y, Fujimoto KD. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet 2001; 103:241-244.